Neutrophil Recruitment Inhibitory Factor: A Novel Cytokine
Author Information
Author(s): W. M. S. C. Tamashiro, B. M. Tavares-Murta, F. Q. Cunha, M. C. Roque-Barreira, R. M. D. Nogueira, S. H. Ferreira
Primary Institution: Faculty of Medicine of Ribeiro Preto, USP
Hypothesis
The study aims to characterize the biological properties of a novel cytokine, referred to as Neutrophil Recruitment Inhibitory Factor (NRIF), which inhibits neutrophil migration.
Conclusion
The study suggests that NRIF is a novel cytokine that inhibits neutrophil migration to inflammatory sites.
Supporting Evidence
- The P2 fraction from macrophage supernatants inhibited neutrophil migration in vivo.
- NRIF did not inhibit in vitro neutrophil chemotaxis induced by FMLP.
- P2 fraction was effective against various inflammatory stimuli but did not affect dextran-induced oedema.
Takeaway
This study found a new factor that can stop certain white blood cells from moving to places in the body where there's inflammation, which could help treat diseases like asthma.
Methodology
The study involved using adult male Wistar rats, stimulating macrophages with lipopolysaccharide, and performing gel filtration chromatography to isolate the P2 fraction that exhibited inhibitory activity.
Limitations
The study does not clarify the precise mechanism of action of NRIF and suggests that further experiments with more purified material are needed.
Participant Demographics
Adult male Wistar rats weighing 150-180 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website